Tapewire

Nasdaq · USD

CME

CME GROUP INC.

Export transactions ↓
Tapewire entity
2909
SEC CIK
0001156375
Parsed reports
929

Last 12 months

Inside the activity.

7 purchase rows · 18 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202522
Jan 202600
Feb 202603
Mar 202624
Apr 202600
May 202603
Jun 202620
Jul 202600
Aug 202600
Sep 202613
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 15, 2026 Filed Mar 17, 2026 16:24 UTC
Marcus Jonathan LSr MD General Counsel
GrantCommon Stock Class A 5,270 $311.40 $1,641,078.00
Disclosure

SEC source: 0001628280-26-018544 · wk-form4_1773764642.xml · nonDerivative · entry 1

Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,121

F1 · shares: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC
Piell Hilda HarrisSr MD & Chief HR Officer
Tax withholdingCommon Stock Class A 3,039 $311.40 $946,344.60
Disclosure

SEC source: 0001628280-26-018543 · wk-form4_1773764636.xml · nonDerivative · entry 2

Piell Hilda Harris · CIK 0001409789 · Sr MD & Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,455

F2 · shares: Ms. Piell surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC
Piell Hilda HarrisSr MD & Chief HR Officer
GrantCommon Stock Class A 7,076 $311.40 $2,203,466.40
Disclosure

SEC source: 0001628280-26-018543 · wk-form4_1773764636.xml · nonDerivative · entry 1

Piell Hilda Harris · CIK 0001409789 · Sr MD & Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,494

F1 · shares: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC
Vroman KenChief Transformation Officer
Tax withholdingCommon Stock Class A 3,135 $311.40 $976,239.00
Disclosure

SEC source: 0001628280-26-018540 · wk-form4_1773764619.xml · nonDerivative · entry 2

Vroman Ken · CIK 0001429863 · Chief Transformation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,851

F2 · shares: Mr. Vroman surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC
Vroman KenChief Transformation Officer
GrantCommon Stock Class A 7,076 $311.40 $2,203,466.40
Disclosure

SEC source: 0001628280-26-018540 · wk-form4_1773764619.xml · nonDerivative · entry 1

Vroman Ken · CIK 0001429863 · Chief Transformation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,986

F1 · shares: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC
DUFFY TERRENCE ADirector · Chairman and CEO
Tax withholdingCommon Stock Class A 27,866 $311.40 $8,677,472.40
Disclosure

SEC source: 0001628280-26-018541 · wk-form4_1773764625.xml · nonDerivative · entry 2

DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,630

F2 · shares: Mr. Duffy surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC
DUFFY TERRENCE ADirector · Chairman and CEO
GrantCommon Stock Class A 62,902 $311.40 $19,587,682.80
Disclosure

SEC source: 0001628280-26-018541 · wk-form4_1773764625.xml · nonDerivative · entry 1

DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,496

F1 · shares: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC
Winkler JulieSr MD Chief Commercial Officer
Tax withholdingCommon Stock Class A 3,658 $311.40 $1,139,101.20
Disclosure

SEC source: 0001628280-26-018539 · wk-form4_1773764613.xml · nonDerivative · entry 2

Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,110

F2 · shares: Ms. Winkler surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC
Winkler JulieSr MD Chief Commercial Officer
GrantCommon Stock Class A 8,256 $311.40 $2,570,918.40
Disclosure

SEC source: 0001628280-26-018539 · wk-form4_1773764613.xml · nonDerivative · entry 1

Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,768

F1 · shares: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC
Fitzpatrick LynnePresident and CFO
Tax withholdingCommon Stock Class A 76 $311.40 $23,666.40
Disclosure

SEC source: 0001628280-26-018536 · wk-form4_1773764601.xml · nonDerivative · entry 3

Fitzpatrick Lynne · CIK 0001915955 · President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,913

F3 · shares: Ms. Fitzpatrick surrendered shares to the company to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2026.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC
Fitzpatrick LynnePresident and CFO
Tax withholdingCommon Stock Class A 2,439 $311.40 $759,504.60
Disclosure

SEC source: 0001628280-26-018536 · wk-form4_1773764601.xml · nonDerivative · entry 2

Fitzpatrick Lynne · CIK 0001915955 · President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,989

F2 · shares: Ms. Fitzpatrick surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC
Fitzpatrick LynnePresident and CFO
GrantCommon Stock Class A 5,504 $311.40 $1,713,945.60
Disclosure

SEC source: 0001628280-26-018536 · wk-form4_1773764601.xml · nonDerivative · entry 1

Fitzpatrick Lynne · CIK 0001915955 · President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,428

F1 · shares: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC
Sammann DerekSr MD Gl Hd Commodities Mkts
Tax withholdingCommon Stock Class A 3,627 $311.40 $1,129,447.80
Disclosure

SEC source: 0001628280-26-018538 · wk-form4_1773764607.xml · nonDerivative · entry 2

Sammann Derek · CIK 0001475318 · Sr MD Gl Hd Commodities Mkts

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,312

F2 · shares: Mr. Sammann surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC
Sammann DerekSr MD Gl Hd Commodities Mkts
GrantCommon Stock Class A 8,256 $311.40 $2,570,918.40
Disclosure

SEC source: 0001628280-26-018538 · wk-form4_1773764607.xml · nonDerivative · entry 1

Sammann Derek · CIK 0001475318 · Sr MD Gl Hd Commodities Mkts

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,939

F1 · shares: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC
Cutinho SunilChief Information Officer
Tax withholdingCommon Stock Class A 3,658 $311.40 $1,139,101.20
Disclosure

SEC source: 0001628280-26-018534 · wk-form4_1773764588.xml · nonDerivative · entry 2

Cutinho Sunil · CIK 0001619400 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,586

F2 · shares: Mr. Cutinho surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC
Cutinho SunilChief Information Officer
GrantCommon Stock Class A 8,256 $311.40 $2,570,918.40
Disclosure

SEC source: 0001628280-26-018534 · wk-form4_1773764588.xml · nonDerivative · entry 1

Cutinho Sunil · CIK 0001619400 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,244

F1 · shares: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC
Tobin Jack JMD Chief Accounting Officer
Tax withholdingCommon Stock Class A 179 $311.40 $55,740.60
Disclosure

SEC source: 0001628280-26-018535 · wk-form4_1773764594.xml · nonDerivative · entry 2

Tobin Jack J · CIK 0001638430 · MD Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,409

F2 · shares: Mr. Tobin surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 16:23 UTC
Tobin Jack JMD Chief Accounting Officer
GrantCommon Stock Class A 608 $311.40 $189,331.20
Disclosure

SEC source: 0001628280-26-018535 · wk-form4_1773764594.xml · nonDerivative · entry 1

Tobin Jack J · CIK 0001638430 · MD Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,588

F1 · shares: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.

Read SEC document
March 12, 2026 Filed Mar 12, 2026 21:46 UTC
Vroman KenChief Transformation Officer
SaleCommon Stock Class A 5,160 $309.00 $1,594,440.00
Disclosure

SEC source: 0001628280-26-017392 · wk-form4_1773351981.xml · nonDerivative · entry 1

Vroman Ken · CIK 0001429863 · Chief Transformation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,910

F1 · price: On March 12, 2026, Mr. Vroman sold an aggregate of 5160 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $308.969 to $309.11. The Company maintains a record of the transaction and copies will be provided upon request.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:48 UTC
Tobin Jack JMD Chief Accounting Officer
GiftCommon Stock Class A 105 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-017394 · wk-form4_1773352078.xml · nonDerivative · entry 1

Tobin Jack J · CIK 0001638430 · MD Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,980

Read SEC document
March 06, 2026 Filed Mar 9, 2026 20:31 UTC SaleCommon Stock Class A 1,000 $320.00 $320,000.00
Disclosure

SEC source: 0001628280-26-016053 · wk-form4_1773088277.xml · nonDerivative · entry 1

Cook Elizabeth A · CIK 0001643475 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · by Trust

Disclosed balance after: 17,771

Read SEC document
February 23, 2026 Filed Feb 23, 2026 21:46 UTC SaleCommon Stock Class A 4,200 $309.65 $1,300,530.00
Disclosure

SEC source: 0001628280-26-010703 · wk-form4_1771883194.xml · nonDerivative · entry 1

Durkin Bryan T · CIK 0001341363 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,007

F1 · price: On February 23, 2026, Mr. Durkin sold an aggregate of 4,200 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $309.25 to $310.07. The Company maintains a record of the transaction and copies will be provided upon request.

Read SEC document
February 20, 2026 Filed Feb 20, 2026 19:07 UTC SaleCommon Stock Class A 300 $305.90 $91,770.00
Disclosure

SEC source: 0001628280-26-010122 · wk-form4_1771614454.xml · nonDerivative · entry 1

GEPSMAN MARTIN J · CIK 0001212813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,999

Read SEC document
February 06, 2026 Filed Feb 9, 2026 18:03 UTC SaleCommon Stock Class A 748 $300.00 $224,400.00
Disclosure

SEC source: 0001628280-26-006282 · wk-form4_1770660210.xml · nonDerivative · entry 1

Suskind Dennis · CIK 0001361519 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,699

Read SEC document
December 31, 2025 Filed Jan 2, 2026 19:28 UTC
DUFFY TERRENCE ADirector · Chairman and CEO
Tax withholdingCommon Stock Class A 10,210 $273.08 $2,788,146.80
Disclosure

SEC source: 0001628280-26-000083 · wk-form4_1767382112.xml · nonDerivative · entry 1

DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,594

F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 12/31/2025.

Read SEC document
December 30, 2025 Filed Jan 2, 2026 19:30 UTC PurchaseCommon Stock Class A 251.21 $278.37 $69,929.33
Disclosure

SEC source: 0001628280-26-000085 · wk-form4_1767382233.xml · nonDerivative · entry 2

SHEPARD WILLIAM R · CIK 0001212852 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · by Trust

Disclosed balance after: 258,709.76

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Actual amounts of fractional shares owned may vary slightly due to rounding.

Read SEC document
December 30, 2025 Filed Jan 2, 2026 19:30 UTC PurchaseCommon Stock Class A 11.06 $278.37 $3,078.77
Disclosure

SEC source: 0001628280-26-000085 · wk-form4_1767382233.xml · nonDerivative · entry 1

SHEPARD WILLIAM R · CIK 0001212852 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,477.39

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Actual amounts of fractional shares owned may vary slightly due to rounding.

Read SEC document
December 11, 2025 Filed Dec 15, 2025 20:05 UTC
DUFFY TERRENCE ADirector · Chairman and CEO
SaleCommon Stock Class A 11,911 $270.05 $3,216,565.55
Disclosure

SEC source: 0001628280-25-056950 · wk-form4_1765829120.xml · nonDerivative · entry 2

DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,804

F1 · price: On December 11, 2025, Mr. Duffy sold an aggregate of 25,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $268.66 to $269.66 for 13,809 shares and $269.68 to $270.51 for 11,911 shares. The Company maintains a record of the transaction and copies will be provided upon request.

Read SEC document
December 11, 2025 Filed Dec 15, 2025 20:05 UTC
DUFFY TERRENCE ADirector · Chairman and CEO
SaleCommon Stock Class A 13,089 $269.10 $3,522,249.90
Disclosure

SEC source: 0001628280-25-056950 · wk-form4_1765829120.xml · nonDerivative · entry 1

DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,715

F1 · price: On December 11, 2025, Mr. Duffy sold an aggregate of 25,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $268.66 to $269.66 for 13,809 shares and $269.68 to $270.51 for 11,911 shares. The Company maintains a record of the transaction and copies will be provided upon request.

Read SEC document
November 20, 2025 Filed Nov 21, 2025 21:09 UTC
Sammann DerekSr MD Gl Hd Commodities Mkts
SaleCommon Stock Class A 1,314 $275.74 $362,322.36
Disclosure

SEC source: 0001475318-25-000007 · wk-form4_1763759380.xml · nonDerivative · entry 4

Sammann Derek · CIK 0001475318 · Sr MD Gl Hd Commodities Mkts

10b5-1 filing: No plan indicated

Ownership: Indirect · by Spouse

Disclosed balance after: 7,022

Read SEC document
November 20, 2025 Filed Nov 21, 2025 21:09 UTC
Sammann DerekSr MD Gl Hd Commodities Mkts
SaleCommon Stock Class A 5,886 $275.65 $1,622,475.90
Disclosure

SEC source: 0001475318-25-000007 · wk-form4_1763759380.xml · nonDerivative · entry 3

Sammann Derek · CIK 0001475318 · Sr MD Gl Hd Commodities Mkts

10b5-1 filing: No plan indicated

Ownership: Indirect · by Trust

Disclosed balance after: 11,028

Read SEC document
November 07, 2025 Filed Nov 12, 2025 13:57 UTC
Piell Hilda HarrisSr MD & Chief HR Officer
GiftCommon Stock Class A 973 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-051367 · wk-form4_1762955862.xml · nonDerivative · entry 1

Piell Hilda Harris · CIK 0001409789 · Sr MD & Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,418

F1 · shares: This transaction involved a gift of securities from the reporting person to her donor advised fund.

Read SEC document
November 06, 2025 Filed Nov 21, 2025 21:09 UTC
Sammann DerekSr MD Gl Hd Commodities Mkts
OtherCommon Stock Class A 2,300 $0.00 $0.00
Disclosure

SEC source: 0001475318-25-000007 · wk-form4_1763759380.xml · nonDerivative · entry 2

Sammann Derek · CIK 0001475318 · Sr MD Gl Hd Commodities Mkts

10b5-1 filing: No plan indicated

Ownership: Indirect · by Trust

Disclosed balance after: 16,914

F1 · balance_after: Ownership has been updated to reflect the transfer of CME Group Class A common stock on November 6, 2025 to reporting person's revocable living trust.

Read SEC document
November 06, 2025 Filed Nov 21, 2025 21:09 UTC
Sammann DerekSr MD Gl Hd Commodities Mkts
OtherCommon Stock Class A 2,300 $0.00 $0.00
Disclosure

SEC source: 0001475318-25-000007 · wk-form4_1763759380.xml · nonDerivative · entry 1

Sammann Derek · CIK 0001475318 · Sr MD Gl Hd Commodities Mkts

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,683

F1 · balance_after: Ownership has been updated to reflect the transfer of CME Group Class A common stock on November 6, 2025 to reporting person's revocable living trust.

Read SEC document
November 03, 2025 Filed Nov 4, 2025 16:34 UTC SaleCommon Stock Class A 1,000 $263.53 $263,530.00
Disclosure

SEC source: 0001156375-25-000208 · wk-form4_1762274042.xml · nonDerivative · entry 1

Ford Harold Eugene Jr. · CIK 0001799464 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,091

F1 · price: On November 3, 2025, Mr. Ford sold an aggregate of 1,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $263.21 to $263.68. The Company maintains a record of the transaction and copies will be provided upon request.

Read SEC document
September 25, 2025 Filed Sep 27, 2025 00:46 UTC PurchaseCommon Stock Class A 11.57 $265.22 $3,068.58
Disclosure

SEC source: 0001628280-25-042985 · wk-form4_1758933959.xml · nonDerivative · entry 2

SHEPARD WILLIAM R · CIK 0001212852 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,466.33

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Actual amounts of fractional shares owned may vary slightly due to rounding.

Read SEC document
September 25, 2025 Filed Sep 27, 2025 00:46 UTC PurchaseCommon Stock Class A 262.465 $265.19 $69,603.09
Disclosure

SEC source: 0001628280-25-042985 · wk-form4_1758933959.xml · nonDerivative · entry 1

SHEPARD WILLIAM R · CIK 0001212852 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · by Trust

Disclosed balance after: 258,458.552

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Actual amounts of fractional shares owned may vary slightly due to rounding.

Read SEC document
September 18, 2025 Filed Sep 18, 2025 23:30 UTC
Marcus Jonathan LSr MD General Counsel
SaleCommon Stock Class A 392 $262.00 $102,704.00
Disclosure

SEC source: 0001952996-25-000007 · wk-form4_1758238225.xml · nonDerivative · entry 1

Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,851

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 18, 2025

Read SEC document
September 16, 2025 Filed Sep 17, 2025 13:48 UTC
Dennis Michael G.Global Head of Fixed Income
Tax withholdingCommon Stock Class A 289 $259.83 $75,090.87
Disclosure

SEC source: 0001811883-25-000005 · wk-form4_1758131315.xml · nonDerivative · entry 2

Dennis Michael G. · CIK 0001811883 · Global Head of Fixed Income

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,638.3766

F1 · shares: Mr. Dennis surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 16, 2025.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 13:48 UTC
McCourt Timothy FrancisSr MD Global Head Equity & FX
SaleCommon Stock Class A 379 $259.83 $98,475.57
Disclosure

SEC source: 0001917308-25-000006 · wk-form4_1758131309.xml · nonDerivative · entry 3

McCourt Timothy Francis · CIK 0001917308 · Sr MD Global Head Equity & FX

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,508

F2 · shares: Mr. McCourt surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 16, 2025.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 17:49 UTC
Cutinho SunilChief Information Officer
Tax withholdingCommon Stock Class A 379 $259.83 $98,475.57
Disclosure

SEC source: 0001619400-25-000007 · wk-form4_1758131363.xml · nonDerivative · entry 3

Cutinho Sunil · CIK 0001619400 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,988

F2 · shares: Mr. Cutinho surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 16, 2025.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 17:49 UTC
Winkler JulieSr MD Chief Commercial Officer
Tax withholdingCommon Stock Class A 379 $259.83 $98,475.57
Disclosure

SEC source: 0001692514-25-000005 · wk-form4_1758131357.xml · nonDerivative · entry 3

Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,512

F2 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 16, 2025.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 17:49 UTC
Marcus Jonathan LSr MD General Counsel
Tax withholdingCommon Stock Class A 294 $259.83 $76,390.02
Disclosure

SEC source: 0001952996-25-000005 · wk-form4_1758131342.xml · nonDerivative · entry 4

Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,243

F3 · shares: Mr. Marcus surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 16, 2025.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 17:49 UTC
Marcus Jonathan LSr MD General Counsel
SaleCommon Stock Class A 376 $258.96 $97,368.96
Disclosure

SEC source: 0001952996-25-000005 · wk-form4_1758131342.xml · nonDerivative · entry 3

Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,537

F2 · shares: This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 18, 2025.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 17:49 UTC
Vroman KenChief Transformation Officer
Tax withholdingCommon Stock Class A 325 $259.83 $84,444.75
Disclosure

SEC source: 0001429863-25-000005 · wk-form4_1758131351.xml · nonDerivative · entry 3

Vroman Ken · CIK 0001429863 · Chief Transformation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,070

F2 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 16, 2025.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 17:48 UTC
Sprague SuzanneCOO & Global Head of Clearing
Tax withholdingCommon Stock Class A 325 $259.83 $84,444.75
Disclosure

SEC source: 0001914409-25-000005 · wk-form4_1758131336.xml · nonDerivative · entry 3

Sprague Suzanne · CIK 0001914409 · COO & Global Head of Clearing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,847

F2 · shares: Ms. Sprague surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 16, 2025.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 17:48 UTC
Tobin Jack JMD Chief Accounting Officer
Tax withholdingCommon Stock Class A 57 $259.83 $14,810.31
Disclosure

SEC source: 0001638430-25-000005 · wk-form4_1758131321.xml · nonDerivative · entry 3

Tobin Jack J · CIK 0001638430 · MD Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,085

F2 · shares: Mr. Tobin surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 16, 2025.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 17:48 UTC
Fitzpatrick LynnePresident and CFO
Tax withholdingCommon Stock Class A 379 $259.83 $98,475.57
Disclosure

SEC source: 0001915955-25-000005 · wk-form4_1758131329.xml · nonDerivative · entry 3

Fitzpatrick Lynne · CIK 0001915955 · President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,924

F2 · shares: Ms. Fitzpatrick surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 16, 2025.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 17:48 UTC
Sammann DerekSr MD Gl Hd Commodities Mkts
Tax withholdingCommon Stock Class A 379 $259.83 $98,475.57
Disclosure

SEC source: 0001475318-25-000005 · wk-form4_1758131304.xml · nonDerivative · entry 3

Sammann Derek · CIK 0001475318 · Sr MD Gl Hd Commodities Mkts

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,983

F2 · shares: Mr. Sammann surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 16, 2025.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 17:44 UTC
Piell Hilda HarrisSr MD & Chief HR Officer
Tax withholdingCommon Stock Class A 325 $259.83 $84,444.75
Disclosure

SEC source: 0001409789-25-000009 · wk-form4_1758131089.xml · nonDerivative · entry 3

Piell Hilda Harris · CIK 0001409789 · Sr MD & Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,391

F2 · shares: Ms. Piell surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 16, 2025.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.